Key Takeaways FDA has launched an aggressive new crackdown on direct-to-consumer (DTC) drug advertising, issuing nearly 100 cease-and-desist letters and thousands of notices — many targeting ...

Artificial intelligence is poised to dramatically reshape the process of developing and approving new medicines, according to ...

The Pharmaceutical Research and Manufacturers of America (PhRMA), a lobbying organization, announced a new website on Monday that will connect patients with manufacturer-direct purchase programs. The ...

Rapt Therapeutics (RAPT) announced that the U.S. FDA has cleared Rapt’s Investigational New Drug Application to proceed to a Phase 2b clinical ...

Francer is Lilly’s vice president, head of global regulatory policy and strategy. Cruz is Lilly’s senior vice president, ...

SOUTH SAN FRANCISCO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: RAPT), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing nove ...

Laxmi Patel explains how providers can meet potential new Medicaid documentation requirements without harming patient access.

Conavi Medical has submitted its Novasight Hybrid™ IVUS/OCT intravascular imaging system to the US Food and Drug ...

These pioneers are aiming to do challenging and important medical work. One has already implanted 54 patients.

According to Precedence Research, the global cord blood banking services market size will grow from USD 3.27 billion in 2025 to nearly USD 5.81 billion by 2034, with a CAGR of 6.61%. Driven by the ...

Conavi announced today that it submitted its next-generation Novasight Hybrid intravascular imaging system for FDA 510(k) ...